BlackRock, Inc. Increases Stake in Aura Biosciences Inc.

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased ownership in Aura Biosciences Inc. As of October 17, 2025, BlackRock owns 3,336,027 shares of Aura Biosciences' common stock, representing a 5.4% ownership stake. This marks an increase of 233,503 shares from their previous holdings, with the value of their investment rising by approximately $1.23 million. BlackRock has indicated that these shares were acquired in the ordinary course of business and not for the purpose of influencing the control of Aura Biosciences. The filing also notes that various persons have the right to receive dividends or proceeds from the sale of these shares, but no single person's interest exceeds 5% of the total outstanding shares.